Related Experiment Video
Updated: Jul 4, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
Nanoparticle-Mediated "Cut-Off and Clean-Up" Strategy for Neutrophil Manipulation in Acute Lung Injury Therapy
Jiaxin Li1, Yeyi Hu1, Shuang Chen1
1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
This study introduces a novel "cut-off and clean-up" strategy using S-DE/GD nanoparticles to treat acute lung injury (ALI). The approach targets polymorphonuclear neutrophils (PMNs) to reduce inflammation and improve therapeutic outcomes.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Immunology
Background:
- Polymorphonuclear neutrophils (PMNs) drive acute lung injury (ALI) through uncontrolled infiltration and inflammation.
- Targeting PMN activity is crucial for effective ALI treatment.
Purpose of the Study:
- To develop a novel therapeutic strategy for ALI by manipulating PMN behavior.
- To design S-DE/GD nanoparticles for targeted PMN inhibition and clearance.
Main Methods:
- Constructed S-DE/GD nanoparticles with liposomes, sulfated hyaluronic acid (SHA), and glucose-modified doxorubicin (GD).
- Utilized SHA to inhibit PMN infiltration by targeting P-selectin.
- Engineered GD for endosomal escape and selective uptake by PMNs via glucose transporter-1.
Main Results:
- S-DE/GD nanoparticles effectively inhibited PMN infiltration in an ALI mouse model.
- Demonstrated significant therapeutic efficacy in treating ALI.
- The strategy successfully reduced PMN-driven inflammation and lung damage.
Conclusions:
- The
- cut-off and clean-up
- strategy using S-DE/GD shows promise for ALI treatment.
- Targeted PMN manipulation offers a new avenue for managing inflammatory lung diseases.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:

